The Nobel Prize in Physiology and Medicine 2012 was awarded to Shinya Yamanaka and John Gurdon for their discovery that mature cells can be reprogrammed to become pluripotent. Their work has now galvanized the stem cell field into generating patient-derived induced pluripotent stem cells (iPSCs) and using these to model and treat human disease. While these efforts are still in their infancy, other types of stem cells are closer to the clinic, and some of them are moving through clinical trials. The overall goal of the symposium is to bring these two areas of stem cell research together to accelerate progress in the field.
Program Themes
FULL INFORMATION & REGISTRATION
Keynote Speakers
George Q. Daley, Boston Children’s Hospital, Harvard Medical School, USA
Sally Temple, Neural Stem Cell Institute, Rensselaer, USA
Confirmed Speakers
Juan Carlos Izpisua Belmonte, Salk Institute, USA / CMRB, Spain
Chad Cowan, Harvard University, USA
Kevin Eggan, Harvard University, USA
Fred H. Gage, Salk Institute, USA
Steven A. Goldman, University of Rochester Medical Center, USA
Eduardo Marbán, Cedars-Sinai, USA
Daniel R. Marshak, PerkinElmer
Christine Mummery, Leiden University Medical Centre, The Netherlands
Janet Rossant, Hospital for Sick Children, Toronto, Canada
Peter G. Schultz, Scripps Research Institute, USA
Deepak Srivastava, Gladstone Institute, USA
Lorenz Studer, Memorial Sloan-Kettering Cancer Center, USA
Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute, USA
Alan Trounson, CIRM, USA
Nobuko Uchida, StemCells Inc., USA
Amy J. Wagers, Harvard University, Joslin Diabetes Center, USA
Leonard I. Zon, Boston Children’s Hospital, Harvard Medical School, USA
Organizing Committee
Gabriel Hayes, Scientific Editor, Cell
Christina Lilliehook, Senior Scientific Editor, Cell Stem Cell
Clive Svendsen, Director, Cedars-Sinai Regenerative Medicine Institute, USA
